席尔德纳菲尔在初级冠状动脉慢流现象中的有效性:试点随机对照临床试验
Abbas Andishmand1, Seyedmostafa Seyedhosseini1, Seyedeh Mahdieh Namayandeh2,3
1Yazd Cardiovascular Research Center, Non-communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Open heart
|August 30, 2024
概括
在冠状动脉慢流现象 (CSFP) 患者中,西尔德纳菲尔显著改善了心痛的严重程度和功能能力. 这项试点研究表明,每天低剂量西尔代纳菲尔作为CSFP的潜在治疗方法.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 冠状动脉缓慢流现象 (CSFP) 与胸痛,心肌梗塞和心脏突然死亡有关.
- 初级CSFP的最佳治疗方法仍未确定,需要进一步研究.
研究的目的:
- 评估西尔代纳菲尔在治疗初级CSFP中的有效性.
- 评估西尔代纳菲尔对心痛严重程度,功能能力和运动耐受性的影响.
主要方法:
- 一个为期12周的,三盲,随机,安慰剂对照试验,涉及20名初级CSFP患者.
- 患者每天接受50毫克口服西尔代纳菲尔或安慰剂.
- 主要结局包括心痛严重程度 (CCS类),功能能力 (METs) 和杜克跑步机得分 (DTS) 的变化.
主要成果:
- 西尔德纳菲尔组在心痛严重程度上显著改善,所有患者都达到CCS类I (无症状).
- 与安慰剂相比,西尔德纳菲尔组的功能能力 (METs) 和杜克跑步机得分 (DTS) 显著增加.
- 在西尔德纳菲尔组中,中位数METs增加了3.1,中位数DTS增加了5.5,而在安慰剂组中变化很小.
结论:
- 每日低剂量西尔代纳菲尔是一种有前途的治疗选择,用于初级CSFP.
- 西尔德纳菲尔有效地缓解症状,并改善CSFP患者的运动耐受性.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
136
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
136
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
464
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
464
Antianginal Drugs: Nitrates and β-Blockers
547
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
547
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Antihypertensive Drugs: Vasodilators
492
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
492


